Yong Yuan - Worldwide Health Economics and Outcomes Research, Bristol Myers Squibb

基本信息

浏览量：17

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 61 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Real-world Clinical Outcomes in Patients with Advanced ROS1+non-small Cell Lung Cancer in the US

Reginald Villacorta, Saurabh Ray,Yong Yuan, Sushupta Vijapur, Sonia Kim, Haiyan Sun, Sky Myers,Vincent Lam

Cancer Researchno. 6_Supplement (2024): 3817-3817

引用0浏览0引用

Unanchored Population-Adjusted Indirect Comparison Methods for Time-to-Event Outcomes Using Inverse Odds Weighting, Regression Adjustment, and Doubly Robust Methods with Either Individual Patient or Aggregate Data

Julie E. Park,Harlan Campbell,Kevin Towle,Yong Yuan,Jeroen P. Jansen,David Phillippo,Shannon Cope

VALUE IN HEALTHno. 3 (2024): 278-286

引用1浏览0WOS引用

Real-world Long-Term Survival Outcomes of First-Line Immunotherapy-Based Regimens in Advanced Non-Small Cell Lung Cancer

David Waterhouse, Saurabh Ray,Keith A. Betts,Sophie Gao,Yong Yuan,Manasvi Sundar, Shumin Rui,David Stenehjem

CANCER RESEARCHno. 6 (2024)

引用0浏览0引用

EP11.03-23 Efficacy of Nivolumab + Ipilimumab Vs Other First-line Treatments for Metastatic NSCLC with PD-L1 <1%: a Network Meta-analysis

K. O'Byrne,E. Popoff,F. Badin,A. Lee,Y. Yuan,S. Goring, L.J. Eccles,N. Varol,N. Waser,J.R. Penrod,G. Lozano-Ortega

Journal of Thoracic Oncologyno. 11 (2023): S629-S630

引用0浏览0引用

MIXTURE-CURE MODELLING OF THE OVERALL SURVIVAL OUTCOMES OF PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (ANSCLC) RECEIVING NIVOLUMAB plus IPILIMUMAB IN CHECKMATE-227

R. Young, C. Pritchard,Y. Yuan,M. Chaudhary,A. Lee,J. Gordon,P. McEwan

VALUE IN HEALTH（2022）

引用0浏览0引用

EE513 Health Economic Evaluation Incorporating Mixture Cure Survival Analysis of Nivolumab Plus Ipilimumab for Previously Untreated Metastatic NSCLC

A. Griffiths,R. Young,Y. Yuan,M. Chaudhary,A. Lee,J. Gordon,P. McEwan

Value in Health（2022）

引用0浏览0引用

The Efficacy and Safety Analysis of First-Line Immune Checkpoint Inhibitors in Pulmonary Sarcomatoid Carcinoma

Zhimin Zeng,Xiaoying Qian,Fanrong Liu,Yong Wang,Yong Yuan,Chen Fang,Xinwei Zhang,Shangkun Yuan,Renfang Chen,Biao Yu,Tong Wang,Yan Yin,Yong Li,Anwen Liu

Frontiers in Immunology（2022）

引用14浏览0WOS引用

MSR16 Mixture-Cure Modelling of Overall Survival of Patients with Metastatic Non-Small Cell Lung Cancer Receiving Nivolumab + Ipilimumab in CheckMate 277 – Updated with 5 Years of Follow-up

R. Young, C. Pritchard,Y. Yuan,M. Chaudhary,A. Lee,J. Gordon,P. McEwan

VALUE IN HEALTH（2022）

引用0浏览0引用

The Economic Burden of Small Cell Lung Cancer: A Systematic Review of the Literature

Ashley Enstone, Maire Greaney,Manca Povsic,Robin Wyn,John R. Penrod,Yong Yuan

PharmacoEconomics - Openno. 2 (2018): 125-139

引用12浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn